Protagonist Therapeutics Inc buy BTIG Research
Start price
24.07.24
/
50%
€50.50
Target price
24.07.25
€46.93
Performance (%)
-4.16%
End price
25.07.25
€48.40
Summary
This prediction ended on 25.07.25 with a price of €48.40. With a performance of -4.16%, the BUY prediction for Protagonist Therapeutics Inc by BTIG_Research closed slightly in the red. BTIG_Research has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -0.676% | -0.676% | 237.156% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by BTIG_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BTIG Research from $41.00 to $51.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten
Current prediction by BTIG_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€70.34
28.10.26
28.10.26
11.36%
18.12.25
18.12.25
